Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia

Respiration

Volumn 76, Issue 1, 2008, Pages 102-107

  Baňasová, Alena ^a,b   Maxová, Hana ^a,b   Hampl, Václav ^a,b   Vízek, Martin ^a,b   Povýšilová, Viera ^a,b   Novotná, Jana ^a,b   Vajnerová, Olga ^a,b   Hniličková, Olga ^a,b   Herget, Jan ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Cardiovascular Research Center   (Czech Republic)

Author keywords

Disodium cromoglycate; Hypoxic pulmonary hypertension; Mast cell; Matrix metalloproteinases; Pulmonary vascular remodeling

Indexed keywords

CROMOGLYCATE DISODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; HYPOXIA; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; MALE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ANIMALS; ANOXIA; CELL DEGRANULATION; COLLAGEN; CROMOLYN SODIUM; HYPERTENSION, PULMONARY; MALE; MAST CELLS; PULMONARY ARTERY; RATS; RATS, WISTAR;

EID: 46249128098     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121410     Document Type: Article

References (26)

1. Novotná J, Herget J: Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia. Physiol Res 2002;51:323-334.
2. Novotná J, Herget J: Exposure to chronic hypoxia induces qualitative changes of collagen in the walls of peripheral pulmonary arteries. Life Sci 1998;62:1-12.
3. Herget J, Wilhelm J, Novotná J, Eckhardt A, Vytášek R, Mrázková L, Ošt'ádal M: A possible role of oxidant tissue injury in the development of pulmonary hypertension. Phys Res 2000;49:493-501.
4. Herget J, Novotná J, Bíbová J, Povýš ilová V, Vaňková M, Hampl V: Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2003;285:L199-L208.
5. Vajner L, Vytasek R, Lachmanova V, Uhlik J, Konradova V, Novotna J, Hampl V, Herget J: Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats. Int J Exp Pathol 2006;87:383-391.
6. Maxová H, Novotná J, Vajner L, Vízek M, Vytášek R, Herget J: Hypoxia increases synthesis of metalloproteinases in isolated rat lung mast cells. Phys Res 2002;51:69P.
7. Hampl V, Herget J: Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am Rev Respir Dis 1990;142:619-624.
8. Herget J, Paleček F: Pulmonary arterial blood pressure in closed chest rats. Changes after catecholamines, histamine and serotonin. Arch Int Pharmacodyn Ther 1972;198:107-117.
9. Hampl V, Archer SL, Nelson DP, Weir EK: Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol 1993;75:1748-1757.
10. Herget J, Suggett AJ, Leach E, Barer GR: Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia. Thorax 1978;33:468-473.
11. Wilhelm J, Vankova M, Maxova H, Siskova A: Hydrogen peroxide production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiol Res 2003;52:327-332.
12. Novotná J, Bíbová J, Hampl V, Deyl Z, Herget J: Hyperoxia and recovery from hypoxia alter collagen in peripheral pulmonary arteries similarly. Physiol Res 2001;50:153-163.
13. Gardi C, Martorana PA, Calzoni P, Cavara E, Marcolongo P, de Santi MM, van Even P, Lungarella G: Cardiac collagen changes during the development of right ventricular hypertrophy in tight-skin mice with emphysema. Exp Mol Pathol 1994;60:100-107.
14. Nadziejko CE, Loud AV, Kikkawa Y: Effect of alveolar hypoxia on pulmonary mast cells in vivo. Am Rev Respir Dis 1989;140:743-748.
15. Kay JM, Suyama KL, Keane PM: Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats. Experientia 1981;37:75-76.
16. Mungall IPF: Hypoxia and lung mast cells: influence of disodium cromoglycate. Thorax 1976;31:94-100.
17. Zhu YJ, Kradin R, Brandstetter RD, Staton G, Moss J, Hales CA: Hypoxic pulmonary hypertension in the mast cell-deficient mouse. J Appl Physiol 1983;54:680-686.
18. Tucker A, McMurtry I, Alexander AF, Reeves JT, Grover RF: Lung mast cell density and distribution in chronically hypoxic animals. J Appl Physiol 1977;42:174-178.
19. Matsuo N, Shimoda T, Matsuse H, Obase Y, Asai S, Kohno S: Effects of sodium cromoglycate on cytokine production following antigen stimulation of a passively sensitized human lung model. Ann Allergy Asthma Immunol 2000;84:72-78.
20. Theoharides TC, Wang L, Pang X, Letourneau R, Culm KE, Basu S, Wang Y, Correia I: Cloning and cellular localization of the rat mast cell 78-kDa protein phosphorylated in response to the mast cell 'stabilizer' cromolyn. J Pharmacol Exp Ther 2000;294:810-821.
21. Steiner DR, Gonzalez NC, Wood JG: Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 2003;94:325-334.
22. Hampl V, Herget J: Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 2000;80:1337-1384.
23. Filley GF, Beckwitt HJ, Reeves JT, Mitchell RS: Chronic obstructive bronchopulmonary disease. 2. Oxygen transport in two clinical types. Am J Med 1968;44:26-38.
24. Turato G, Zuin R, Saetta M: Pathogenesis and pathology of COPD. Respiration 2001;68:117-128.
25. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008;75:224-238.
26. Rakusan K, Sarkar K, Turek Z, Wicker P: Mast cells in the rat heart during normal growth and in cardiac hypertrophy. Circ Res 1990;66:511-516.